title: Diabetes and it's complications in a Swedish county.
abstract: A cross-sectional survey with the aim to study the prevalence of diabetes and long-term complications was carried out in a health care district in Sweden with 125,500 inhabitants. Information was extracted from the medical records. 4127 people with diabetes were identified of whom 87% were classified as NIDDM (non-insulin-dependent diabetes mellitus), 12% as IDDM (insulin-dependent diabetes mellitus) and 0.7% as secondary or unclassified diabetes. The prevalence of diagnosed diabetes was 3.3%. A total of 83% received their regular routine care at primary health care centres, 31% were treated with diet only, 36% had oral hypoglycaemic agents, 31% had insulin and 2% had combination therapy. The mean HbA1c was 7.2% (ref. range 4.0-5.3%). Of the adults (> 18 years) 27% had retinopathy, 13% had nephropathy and 27% had loss of pallaesthesia. 50% had hypertension, 21% angina pectoris, 11% had had myocardial infarction, 11% stroke, 21% had signs of peripheral arterial disease, 2% had been amputated and 21% were smokers. The conclusion is that in a population of patients with diabetes with acceptable metabolic control, complications are still a great problem.
authors.affiliation: Department of Advanced Nursing, Umeå University, Sweden. berit.lundman@nurssci.umu.se
authors.forename: B
authors.initials: B
authors.lastname: Lundman
authors.forename: L
authors.initials: L
authors.lastname: Engström
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000419:Albuminuria / Q000150:complications; D002318:Cardiovascular Diseases / Q000150:complications; D003627:Data Interpretation, Statistical; D003922:Diabetes Mellitus, Type 1 / Q000150:complications* / Q000453:epidemiology / Q000628:therapy; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000453:epidemiology / Q000628:therapy; D016883:Diabetic Ketoacidosis / Q000150:complications; D003928:Diabetic Nephropathies / Q000453:epidemiology / Q000628:therapy; D003929:Diabetic Neuropathies / Q000453:epidemiology / Q000628:therapy; D003930:Diabetic Retinopathy / Q000453:epidemiology / Q000628:therapy; D003927:Diet, Diabetic; D005260:Female; D005654:Fundus Oculi; D006442:Glycated Hemoglobin / Q000378:metabolism; D006296:Health Services / Q000706:statistics & numerical data; D006801:Humans; D006973:Hypertension / Q000150:complications; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications; D009887:Ophthalmoscopy; D015995:Prevalence; D011446:Prospective Studies; D012737:Sex Factors; D012907:Smoking; D013453:Sulfonylurea Compounds / Q000627:therapeutic use; D013548:Sweden / Q000453:epidemiology
chemical_list: D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds